Skip to content

A Study on the Stress-Relieving Effects of Vibration Stimulation

A Randomized Controlled Trial on the Effects of Gradually Slowing Tempo Vibration Stimulation on Acute Stress Recovery in Healthy Males - Tempo-Reduced Vibration for Stress Recovery Trial (TRVSR)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058216
Enrollment
42
Registered
2025-06-20
Start date
2021-04-08
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None (Healthy participants)

Interventions

Group 1: Variable vibration stimulation Participants received a 2-minute vibration stimulation while holding a dedicated device. The vibration started at a tempo corresponding to the participant&#39
s resting heart rate (e.g., 75 bpm) and gradually slowed down to either half of the initial heart rate or 50 bpm, whichever was higher. Group 2: Fixed vibration stimulation Participants received a 2-
s resting heart rate or 50 bpm, whichever was higher. Group 3: Control group (no stimulation) Participants held the dedicated vibration device for 2 minutes without receiving any vibration. They rest

Sponsors

POLA Chemical Industries, Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Healthy males aged 20 to 49 years Provided written informed consent after receiving sufficient explanation

Exclusion criteria

Exclusion criteria: Individuals with arrhythmia or cardiovascular disease Individuals taking medication for the above conditions Individuals weighing less than 30 kg or more than 100 kg Individuals using a cardiac pacemaker Individuals deemed unsuitable for participation in the study by the principal investigator

Design outcomes

Primary

MeasureTime frame
Changes in subjective stress indicators (Tense Arousal [TA] and Energetic Arousal [EA] scores) before and after the intervention

Countries

Japan

Contacts

Public Contacttomomi kato

POLA Chemical Industries, Inc. Frontier Research Center

k-tomo@pola.co.jp045-826-7134

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026